Common Contracts

EX-10.12 14 a2225009zex-10_12.htm EX-10.12 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN...

Asset Purchase Agreement • May 5th, 2020 • New York

• Contract Type
  Asset Purchase Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

This Asset Purchase Agreement (this “Agreement”) is made and dated as of August 28, 2014 (the “Closing Date”), between Cornerstone BioPharma, Inc., a Nevada corporation (“Seller”), and Neos Therapeutics, Inc., a corporation organized under the laws of the State of Delaware (“Buyer”). Seller and Buyer may each be referred to herein individually as a “Party” and collectively as the “Parties.”

ASSET PURCHASE AGREEMENT between CORNERSTONE BIOPHARMA, INC. AND NEOS THERAPEUTICS, INC. August 28, 2014

Asset Purchase Agreement • June 19th, 2015 • Neos Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Asset Purchase Agreement
• Filed
  June 19th, 2015
• Company
  Neos Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Asset Purchase Agreement (this “Agreement”) is made and dated as of August 28, 2014 (the “Closing Date”), between Cornerstone BioPharma, Inc., a Nevada corporation (“Seller”), and Neos Therapeutics, Inc., a corporation organized under the laws of the State of Delaware (“Buyer”). Seller and Buyer may each be referred to herein individually as a “Party” and collectively as the “Parties.”